Premature Ovarian Insufficiency (POI)

By RRM Academy Reviewed by Dr. Naomi Whittaker, MD, Board-Certified OBGYN, MIGS, NFPMC, FCI Updated May 14, 2026

Premature Ovarian Insufficiency (POI) is the loss of normal ovarian function before age 40, characterized by amenorrhea, elevated FSH, and reduced estrogen production. The diagnosis requires two FSH measurements above 25 IU/L taken at least four weeks apart in the context of menstrual irregularity or absence before age 40.¹ POI is distinct from diminished ovarian reserve (DOR), where reserve is reduced but follicular activity continues, and from natural menopause, which occurs in the fifth decade.

POI affects approximately 1% of women under 40. Known causes include autoimmune conditions, chromosomal variants (notably fragile X premutation), and iatrogenic damage from chemotherapy or radiation. In the majority of cases the cause remains unidentified. AMH testing can detect declining ovarian reserve earlier than FSH elevation and may help predict progression toward POI, though AMH values carry significant individual variability.² Intermittent ovarian activity occurs in a meaningful proportion of women with established POI, which is why the contemporary term "insufficiency" replaced the older "failure."

The primary health priorities in POI are estrogen replacement to protect bone density and cardiovascular health, and evaluation of thyroid and adrenal autoimmunity, which co-occur more frequently in this population.¹ Because POI touches every dimension of the hormonal axis, full evaluation avoids the error of treating FSH elevation in isolation. Where spontaneous conception is possible due to residual follicular activity, identifying and supporting that window is clinically meaningful within an ovarian reserve framework.

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.